When One More Pap Smear Is One Too Many

By Noller K.L.  

Gynecologic Oncology, Vol. 67, Iss. 1, 1997-10 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Assessment of HER2 status in breast cancer - why, when and how?

By Dowsett M.   Cooke T.   Ellis I.   Gullick W.J.   Gusterson B.   Mallon E.   Walker R.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 170-176

Elsevier

Access to resources Recommend Favorite

Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

By Andreyev H.J.N.   Norman A.R.   Oates J.   Cunningham D.  

European Journal of Cancer, Vol. 34, Iss. 4, 1998-03 ,pp. : 503-509

Elsevier

Access to resources Recommend Favorite

Target Practice: Figuring Out Which, When, and Why to Use Systemic Therapies for Metastatic Colon Cancer

By Holen Kyle  

Cancer Investigation, Vol. 24, Iss. 1, 2006-03 ,pp. : 98-105

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Elderly Patients Affected by Lung Cancer: Why to Treat, when to Treat and what we Know

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 9, 2013-11 ,pp. : 1378-1382

Bentham Science Publishers

Access to resources Recommend Favorite